| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $15.4M | +0.2% |
| Cost of Revenue | $5.1M | +4.4% |
| Gross Profit | $10.2M | -1.8% |
| R&D Expense | $4.0M | -3.3% |
| SG&A Expense | $3.1M | -4.1% |
| Operating Income | -$2.4M | -20.2% |
| Pre-tax Income | -$2.6M | -27.6% |
| Income Tax | -$39K | +9.3% |
| Net Income | -$2.5M |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.6M | +17.0% |
| Accounts Receivable | $1.5M | +19.7% |
| Current Assets | $3.5M | +18.0% |
| Total Assets | $15.3M | -1.8% |
| Current Liabilities | $5.0M | +5.4% |
| Long-term Debt | $326K | -38.0% |
| Total Liabilities | $5.8M | +2.9% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.1M | -44.3% |
| Capital Expenditures | $18K | -37.9% |
| Financing Cash Flow | $1.4M | +750.7% |
| Free Cash Flow | -$1.1M | -41.3% |
| -28.4% |
| EPS (Basic) | -$0.25 | -31.6% |
| EPS (Diluted) | -$0.25 | -31.6% |
| Stockholders' Equity |
| $9.6M |
| -4.4% |